None listed
Conditions
Interventions
Intervention1: Eltior Skin-Revive Serum: Mode of Usage: Approximately 2 3 drops of the serum will be dispensed and gently applied over the face using fingertips, followed by light tapping to aid absor
Sponsors
Relaner Ventures Pvt. Ltd.
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age: 18 to 55 years (both inclusive) at the time of consent. 2) Sex: Adult male and female having Crow s feet area wrinkles, fine lines. 3) Females of childbearing potential should have a self-reported negative urine pregnancy test at the time of screening visit. 4) Study participants should not have used any cosmetic, nutraceutical or therapeutic product for skin ageing in last 3 months. 5) Study participants are not allowed to participate in any other study until this study is complete. 6) Study participants must be willing and able to follow the study directions and to return for all specified visits with the product. 7) Study participants must agree to record each use of the test product in the study participant s diary card on daily basis. 8) Study participants must agree to record medication use during the study
Exclusion criteria
Exclusion criteria: 1) Study participants who are on steroids for last six months. 2) Study participants who have used any cosmetic, nutraceutical or therapeutic product for skin last three months. 3) Study participants with cuts, abrasions, wounds, or broken skin on the fore arm. 4) Study participants who are on product which contains kojic acid, glycolic acid, niacinamide, alpha arbutin, Vitamin C and other skin ageing product. 5) Study participants with other dermatologic diseases whose presence or products could interfere with the assessment of study. 6) Study participants that are pregnant and/or breastfeeding. 7) The study participant has a known allergy or sensitivity to soaps, lotions, detergents, detanglers or fragrances. 8) Study participants if do not agree to limit sun exposure to affected areas such as face during prolonged sun exposure. 9) The study participant has any other skin conditions i.e. cuts, scratches, ring worms, etc. which in the opinion of the Investigator, will interfere with the study results or will create undue risk for the study participant. 10) The study participant has any of the conditions or factors that the Investigator believes may affect the response of the skin or the interpretation of the test results. 11) The study participant is currently taking or has taken any medication, which the Investigator believes may influence the interpretation of the data. 12) Any other condition which could warrant exclusion from the study, as per the dermatologist s/investigator s discretion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To evaluate the effectiveness of the test product in terms of change in skin colour parameters - L, a, b, and ITA from baseline before usage and after usage of the test product. 2.To evaluate the effectiveness of the test product in terms of change in skin elasticity and firmness from baseline before usage and after usage of the test product. 3.To evaluate the effectiveness of the test product in terms of change in skin melanin and erythema from baseline before usage and after usage of the test product. 4.To evaluate the effectiveness of the test product in terms of change in skin hydration from baseline before usage and after usage of the test product. 5. To evaluate the effectiveness of the test product in terms of change in skin barrier function from baseline before usage and after usage of the test product Timepoint: 1. from baseline before usage of the test product on Day 01 and after usage of the test product at T20 min on Day 01, Day 02 and Day 30 . 2. from baseline before usage of the test product on Day 01 and after usage of the test product at T20 min on Day 01, Day 02 and Day 30. 3.from baseline before usage of the test product on Day 01 and after usage of the test product at T20 min on Day 01, Day 02 and Day 30. 4.from baseline before usage of the test product on Day 01 and after usage of the test product at T20 min on Day 01, Day 02 and Day 30 . 5. from baseline before usage of the test product on Day 01 and after usage of the test product at T20 min on Day 01, Day 02 and Day 30 . | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To evaluate the effectiveness of test product in terms of repair skin barrier damage following standardized tape stripping and UV stimulation from baseline before usage and after usage of the test product.Timepoint: before usage of the test product on Day 01 and after usage of the test product at T20 min on Day 01, Day 02 and Day 30;2. To evaluate the effectiveness of the test product in terms of change in skin texture i.e. roughness, scaliness, smoothness and wrinkles from baseline before usage and after usage of the test productTimepoint: before usage of the test product on Day 01 and after usage of the test product at T20 min on Day 01, Day 02 and Day 30;3. To evaluate the effectiveness of test product in terms of change in comedones from baseline before and after usage of the test productTimepoint: before usage of the test product on Day 01 and after usage of the test product at T20 min on Day 01, Day 02 and Day 30;4. To evaluate the effectiveness of the test product in terms of change in acne lesions from baseline before usage and after usage of the test productTimepoint: before usage of the test product on Day 01 and after usage of the test product at T20 min on Day 01, Day 02 and Day 30;5. To evaluate the effectiveness of the test product in terms of change in skin gloss from baseline before usage and after usage of the test productTimepoint: before usage of the test product on Day 01 and after usage of the test product at T20 min on Day 01, Day 02 and Day 30;6. To evaluate the effectiveness of the test product in terms of change in visual appearance of skin from baseline before usage and after usage of the test product.Timepoint: before usage of the test product on Day 01 and after usage of the test product at T20 min on Day 01, Day 02 and Day 30;7. To evaluate the effectiveness of the test product in terms of change in Product Perception Questionnaire from baseline before usage and after usage of the test productTimepoint: before usage of the test produc | — |
Countries
India
Contacts
Public ContactDr Maheshvari Patel
NovoBliss Research Private Limited
Outcome results
None listed